These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1803510)

  • 61. [Coagulation, fibrinolysis and various diseases: diabetes mellitas].
    Abe T
    Nihon Rinsho; 1974 May; 32(5):1072-4. PubMed ID: 4858914
    [No Abstract]   [Full Text] [Related]  

  • 62. Letter: Fibrinolytic activity in treatment of diabetes.
    Bogie W; George J; Crane CW
    Lancet; 1976 Aug; 2(7980):312. PubMed ID: 59882
    [No Abstract]   [Full Text] [Related]  

  • 63. Experimental studies: thrombolytic activity and related pheneomena.
    NYDICK I
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():266-73. PubMed ID: 13939295
    [No Abstract]   [Full Text] [Related]  

  • 64. Blood fibrinolytic activity in diabetes mellitus.
    Sharma SD; Malhotra PP
    Indian J Med Sci; 1969 Jul; 23(7):366-70. PubMed ID: 5824531
    [No Abstract]   [Full Text] [Related]  

  • 65. Dangers of thrombolysis.
    Thomas PD
    BMJ; 1990 Apr; 300(6730):1013. PubMed ID: 2386583
    [No Abstract]   [Full Text] [Related]  

  • 66. [Study of fibrinolytic activity with the aid of the Fearnley test].
    Dascălu M; Kleinstein I; Jurebiţă L; Ludwig I
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(3):625-9. PubMed ID: 4255697
    [No Abstract]   [Full Text] [Related]  

  • 67. Successful application of an assay indicating thrombolytic activity in excess of plasma inhibitors.
    HUME M
    Surg Forum; 1961; 12():44-6. PubMed ID: 14449956
    [No Abstract]   [Full Text] [Related]  

  • 68. Ask Dr. Francis. I read recently that people with diabetes are at high risk for cardiovascular disease. I have diabetes, but am not aware of any other health problems. What can I do to reduce my risk?
    Francis GS
    Heart Advis; 2002 Jul; 5(7):8. PubMed ID: 12173593
    [No Abstract]   [Full Text] [Related]  

  • 69. Resistance to testosterone as a stimulator of blood fibrinolytic activity in patients with cancer of the breast.
    Winther O
    Lancet; 1970 Mar; 1(7647):625. PubMed ID: 4191171
    [No Abstract]   [Full Text] [Related]  

  • 70. ATP-ase as inhibitor of lysokinase and plasminoplastin activators of fibrinolysis in vitro.
    Iatridis PG; Iatridis SG; Ferguson JH
    Proc Soc Exp Biol Med; 1966 Mar; 121(3):788-93. PubMed ID: 4222887
    [No Abstract]   [Full Text] [Related]  

  • 71. [Fibrinolytic activity of cerebro-spinal fluid and the development of artificial haematomas in dogs].
    Mihara H
    Nihon Seirigaku Zasshi; 1968; 30(7):431-41. PubMed ID: 5749258
    [No Abstract]   [Full Text] [Related]  

  • 72. [DETERMINATION OF THROMBOLYTIC ACTIVITY].
    MORELLI AC
    Sangre (Barc); 1965; 10():187-94. PubMed ID: 14316024
    [No Abstract]   [Full Text] [Related]  

  • 73. Experimental studies: thrombolytic activity and related phenomena.
    BANG NU
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():262-5. PubMed ID: 13966347
    [No Abstract]   [Full Text] [Related]  

  • 74. The identification and quantitation of thrombolytic agents 1,2.
    SGOURIS JT; McCALL KB; ANDERSON HD
    Biochem Biophys Res Commun; 1961 Apr; 4():388-92. PubMed ID: 13750528
    [No Abstract]   [Full Text] [Related]  

  • 75. Fibrinolytic response to oral glucose.
    Tanser AR
    Lancet; 1966 Jul; 2(7455):147-8. PubMed ID: 4161631
    [No Abstract]   [Full Text] [Related]  

  • 76. Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitro.
    Fears R; Standring R; Abraham R
    Semin Thromb Hemost; 1991 Oct; 17(4):407-11. PubMed ID: 1803510
    [No Abstract]   [Full Text] [Related]  

  • 77. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

  • 80. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.